A Pilot Study of Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

Trial Profile

A Pilot Study of Brain Irradiation and Tremelimumab in Metastatic Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Nov 2017

At a glance

  • Drugs Tremelimumab (Primary)
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Sep 2018.
    • 05 Apr 2017 First results presented at the 108th Annual Meeting of the American Association for Cancer Research
    • 21 Dec 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top